title: Bioinformatics in new generation flavivirus vaccines.
abstract: Flavivirus infections are the most prevalent arthropod-borne infections world wide, often causing severe disease especially among children, the elderly, and the immunocompromised. In the absence of effective antiviral treatment, prevention through vaccination would greatly reduce morbidity and mortality associated with flavivirus infections. Despite the success of the empirically developed vaccines against yellow fever virus, Japanese encephalitis virus and tick-borne encephalitis virus, there is an increasing need for a more rational design and development of safe and effective vaccines. Several bioinformatic tools are available to support such rational vaccine design. In doing so, several parameters have to be taken into account, such as safety for the target population, overall immunogenicity of the candidate vaccine, and efficacy and longevity of the immune responses triggered. Examples of how bio-informatics is applied to assist in the rational design and improvements of vaccines, particularly flavivirus vaccines, are presented and discussed.
authors.affiliation: Department of Virology, Erasmus Medical Centre, 3000 CA Rotterdam, The Netherlands.
authors.forename: Penelope
authors.initials: P
authors.lastname: Koraka
authors.forename: Byron E E
authors.initials: BE
authors.lastname: Martina
authors.forename: Albert D M E
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D000818:Animals; D019295:Computational Biology / Q000379:methods*; D015195:Drug Design; D005416:Flavivirus; D018177:Flavivirus Infections / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D014765:Viral Vaccines
chemical_list: D014765:Viral Vaccines
references.citation: Mol Ther. 2007 Sep;15(9):1630-9
references.pmid: 17609656
references.citation: Vaccine. 2001 Jun 14;19(27):3700-9
references.pmid: 11395204
references.citation: Virology. 1998 Oct 10;250(1):151-63
references.pmid: 9770429
references.citation: Microbes Infect. 2006 Sep;8(11):2578-86
references.pmid: 16949850
references.citation: FEBS Lett. 1999 Dec 3;462(3):387-91
references.pmid: 10622731
references.citation: J Virol. 2004 Dec;78(24):13975-86
references.pmid: 15564505
references.citation: Lancet. 2004 Jun 19;363(9426):2073-5
references.pmid: 15207960
references.citation: Mol Cell Biol. 2000 Apr;20(8):2926-32
references.pmid: 10733596
references.citation: Methods Mol Biol. 2009;517:55-67
references.pmid: 19378017
references.citation: Mol Biol Evol. 1985 Jan;2(1):13-34
references.pmid: 3916708
references.citation: Biologicals. 2002 Dec;30(4):303-14
references.pmid: 12421588
references.citation: J Infect Dis. 2005 Jan 15;191(2):207-14
references.pmid: 15609230
references.citation: J Gen Virol. 1997 Jul;78 ( Pt 7):1543-9
references.pmid: 9225027
references.citation: Vaccine. 2000 Jul 15;18(27):3113-22
references.pmid: 10856791
references.citation: Hum Gene Ther. 1997 Nov 20;8(17):2019-29
references.pmid: 9414251
references.citation: Gene. 2002 Apr 17;288(1-2):1-8
references.pmid: 12034488
references.citation: J Infect Dis. 2002 Jan 1;185(1):1-12
references.pmid: 11756975
references.citation: J Mol Med (Berl). 2001 Jun;79(5-6):343-50
references.pmid: 11485031
references.citation: Virology. 2006 Jan 20;344(2):412-20
references.pmid: 16226783
references.citation: Vaccine. 2009 Aug 6;27(36):4938-46
references.pmid: 19549606
references.citation: Microbiol Immunol. 2005;49(4):349-53
references.pmid: 15840960
references.citation: Cancer Res. 1999 Feb 15;59(4):826-30
references.pmid: 10029071
references.citation: Nucleic Acids Res. 1990 Oct 11;18(19):5799-805
references.pmid: 2170946
references.citation: Virology. 2005 Sep 1;339(2):200-12
references.pmid: 16002117
references.citation: Am J Trop Med Hyg. 2008 Mar;78(3):426-33
references.pmid: 18337339
references.citation: Lancet. 2007 Nov 10;370(9599):1644-52
references.pmid: 17993365
references.citation: Expert Rev Vaccines. 2009 Aug;8(8):969-72
references.pmid: 19627179
references.citation: Adv Virus Res. 2003;59:23-61
references.pmid: 14696326
references.citation: Cell Host Microbe. 2007 Apr 19;1(2):135-45
references.pmid: 18005691
references.citation: Nucleic Acids Res. 1991 Jun 25;19(12):3185-92
references.pmid: 1905801
references.citation: J Virol. 2007 Oct;81(19):10329-39
references.pmid: 17652394
references.citation: Proc Natl Acad Sci U S A. 1987 Apr;84(7):2019-23
references.pmid: 3470774
references.citation: J Infect Dis. 2006 Jun 15;193(12):1658-65
references.pmid: 16703509
references.citation: Vaccine. 2009 Feb 5;27(6):893-903
references.pmid: 19070640
references.citation: Ann N Y Acad Sci. 2001 Dec;951:272-85
references.pmid: 11797784
references.citation: J Exp Med. 1937 May 31;65(6):787-800
references.pmid: 19870634
references.citation: EMBO J. 1987 Aug;6(8):2489-92
references.pmid: 3311730
references.citation: Vaccine. 2006 Oct 30;24(42-43):6513-25
references.pmid: 16860446
references.citation: J Virol. 2000 May;74(9):4244-52
references.pmid: 10756038
references.citation: Nucleic Acids Res. 1987 Feb 11;15(3):1281-95
references.pmid: 3547335
references.citation: J Gene Med. 2007 May;9(5):392-402
references.pmid: 17407167
references.citation: J Mol Biol. 1981 Feb 15;146(1):1-21
references.pmid: 6167728
references.citation: Gene. 2005 Nov 21;361:13-37
references.pmid: 16213112
references.citation: Vaccine. 2000 May 8;18(22):2426-34
references.pmid: 10738100
references.citation: J Infect Dis. 2008 Mar 1;197(5):693-7
references.pmid: 18266603
references.citation: Biosci Biotechnol Biochem. 2004 Aug;68(8):1634-9
references.pmid: 15322345
references.citation: J Virol. 2004 Aug;78(15):8312-21
references.pmid: 15254203
references.citation: Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45
references.pmid: 10357856
references.citation: J Virol Methods. 2008 Dec;154(1-2):121-7
references.pmid: 18789973
references.citation: J Immunol. 2004 Jul 1;173(1):550-8
references.pmid: 15210816
references.citation: Expert Rev Vaccines. 2007 Oct;6(5):747-59
references.pmid: 17931155
references.citation: Nature. 2009 Apr 30;458(7242):1191-5
references.pmid: 19252480
references.citation: Virology. 2001 Nov 10;290(1):74-82
references.pmid: 11883007
references.citation: J Travel Med. 2007 Jul-Aug;14(4):259-68
references.pmid: 17617849
references.citation: J Gene Med. 2001 Mar-Apr;3(2):153-64
references.pmid: 11318114
references.citation: Nucleic Acids Res. 1989 Sep 12;17(17):6983-98
references.pmid: 2571127
references.citation: Nucleic Acids Res. 1981 Jan 10;9(1):r43-74
references.pmid: 7208352
references.citation: Adv Virus Res. 2003;61:445-68
references.pmid: 14714440
references.citation: J Virol. 1998 May;72(5):4454-7
references.pmid: 9557740
references.citation: AIDS Res Hum Retroviruses. 2003 Sep;19(9):817-23
references.pmid: 14585212
references.citation: Virology. 2002 Aug 15;300(1):125-39
references.pmid: 12202213
references.citation: Mol Immunol. 2006 May;43(12):1941-52
references.pmid: 16442623
references.citation: Int J Mol Med. 2007 Feb;19(2):309-15
references.pmid: 17203206
references.citation: Biochem Biophys Res Commun. 1999 Aug 2;261(2):445-51
references.pmid: 10425204
references.citation: EMBO J. 1995 Jan 16;14(2):217-23
references.pmid: 7835332
references.citation: Bull World Health Organ. 1989;67(4):375-80
references.pmid: 2805215
references.citation: J Exp Med. 2003 Dec 15;198(12):1853-62
references.pmid: 14662909
references.citation: J Infect Dis. 2007 Jun 1;195(11):1607-17
references.pmid: 17471430
references.citation: J Immunol. 1998 Nov 15;161(10):5594-9
references.pmid: 9820537
references.citation: J Virol. 2006 Dec;80(24):12149-59
references.pmid: 17035317
references.citation: J Mol Biol. 1982 Jul 15;158(4):573-97
references.pmid: 6750137
references.citation: J Virol. 1999 Jun;73(6):4972-82
references.pmid: 10233959
references.citation: Vaccine. 2004 Sep 28;22(29-30):3942-6
references.pmid: 15364442
references.citation: Anim Health Res Rev. 2008 Jun;9(1):71-86
references.pmid: 18348742
references.citation: Microbiol Immunol. 2002;46(1):23-8
references.pmid: 11911185
references.citation: Virology. 1998 Jul 5;246(2):317-28
references.pmid: 9657950
references.citation: Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97
references.pmid: 14753386
references.citation: Gene Ther. 2004 Mar;11(6):522-33
references.pmid: 14999224
references.citation: Immunol Rev. 2008 Oct;225:212-25
references.pmid: 18837784
references.citation: Vaccine. 2002 Feb 22;20(11-12):1563-70
references.pmid: 11858863
references.citation: J Virol. 2001 Nov;75(22):10991-1001
references.pmid: 11602739
references.citation: Gene Ther. 2008 Nov;15(22):1489-99
references.pmid: 18563184
references.citation: J Immunol. 2009 Apr 15;182(8):4865-73
references.pmid: 19342665
references.citation: Virology. 1997 Jan 20;227(2):353-60
references.pmid: 9018134
references.citation: FEMS Immunol Med Microbiol. 2009 Jan;55(1):23-33
references.pmid: 19076227
references.citation: Biochem Biophys Res Commun. 2006 Jan 13;339(2):673-8
references.pmid: 16316630
references.citation: Clin Microbiol Rev. 1998 Jul;11(3):480-96
references.pmid: 9665979
references.citation: J Virol. 2001 May;75(9):4040-7
references.pmid: 11287553
references.citation: Nucleic Acids Res. 1991 Jul 25;19(14):3979-86
references.pmid: 1650459
references.citation: Infect Immun. 2005 Sep;73(9):5666-74
references.pmid: 16113284
references.citation: Mol Cells. 1997 Aug 31;7(4):495-501
references.pmid: 9339893
references.citation: J Biol Chem. 2004 Sep 10;279(37):38755-61
references.pmid: 15190071
references.citation: Expert Rev Vaccines. 2005 Jun;4(3):407-17
references.pmid: 16026252
references.citation: Vaccine. 2007 Feb 19;25(9):1634-46
references.pmid: 17145123
references.citation: Hum Vaccin. 2009 Jan-Feb;5(1):33-40
references.pmid: 18670195
references.citation: BMC Infect Dis. 2004 Oct 04;4:39
references.pmid: 15461822
references.citation: Gene. 2001 Jul 11;272(1-2):149-56
references.pmid: 11470520
references.citation: Genes Dev. 1989 Dec;3(12B):2180-90
references.pmid: 2628166
references.citation: J Immunol. 2008 Dec 15;181(12):8568-75
references.pmid: 19050276
references.citation: Mol Cell Biol. 1990 Apr;10(4):1805-10
references.pmid: 1690852
references.citation: Vaccine. 2006 May 22;24(21):4531-40
references.pmid: 16140431
references.citation: Trends Cell Biol. 1998 Oct;8(10):410-5
references.pmid: 9789330
references.citation: Vaccine. 2007 Jul 26;25(30):5563-76
references.pmid: 17292514
references.citation: Clin Vaccine Immunol. 2007 Nov;14(11):1465-71
references.pmid: 17687109
references.citation: J Gene Med. 2004 May;6(5):565-73
references.pmid: 15133767
references.citation: Am J Trop Med Hyg. 2004 Dec;71(6):811-21
references.pmid: 15642976
references.citation: J Virol. 2002 Nov;76(22):11561-9
references.pmid: 12388717
references.citation: Vaccine. 2004 Sep 9;22(27-28):3669-75
references.pmid: 15315846
references.citation: J Gene Med. 2009 Jul;11(7):598-604
references.pmid: 19399759
references.citation: Clin Vaccine Immunol. 2008 Mar;15(3):460-7
references.pmid: 18216185
references.citation: Am J Trop Med Hyg. 2001 Nov;65(5):405-13
references.pmid: 11716091
references.citation: Vaccine. 2007 Jul 20;25(29):5409-16
references.pmid: 17560694
references.citation: Methods Mol Biol. 2009;517:69-79
references.pmid: 19378016
references.citation: Virology. 2002 Jun 20;298(1):146-59
references.pmid: 12093182
references.citation: J Virol. 2008 Jul;82(14):6927-34
references.pmid: 18480438
references.citation: Annu Rev Biomed Eng. 2004;6:397-426
references.pmid: 15255775
references.citation: J Immunol. 2007 Mar 1;178(5):2699-705
references.pmid: 17312111
references.citation: Trends Mol Med. 2008 Sep;14(9):410-8
references.pmid: 18692441
references.citation: Lancet. 2008 Feb 9;371(9611):500-9
references.pmid: 18262042
references.citation: BMC Cell Biol. 2008 Jan 11;9:2
references.pmid: 18190688
references.citation: PLoS Pathog. 2009 Apr;5(4):e1000373
references.pmid: 19360120
references.citation: J Control Release. 2009 May 5;135(3):227-33
references.pmid: 19331843
references.citation: Vaccine. 2008 Feb 6;26(6):817-28
references.pmid: 18191005
references.citation: Nat Biotechnol. 2008 May;26(5):571-7
references.pmid: 18425125
references.citation: Clin Vaccine Immunol. 2007 Sep;14(9):1117-26
references.pmid: 17634508
references.citation: Mol Biol Rep. 2010 Jul;37(6):2757-65
references.pmid: 19757163
references.citation: J Gene Med. 2004 Apr;6(4):395-404
references.pmid: 15079814
references.citation: Microbes Infect. 2006 Jan;8(1):92-104
references.pmid: 16126425
references.citation: J Gen Virol. 2001 Aug;82(Pt 8):1867-1876
references.pmid: 11457992
references.citation: Acta Virol. 2007;51(2):125-30
references.pmid: 17900219
references.citation: Vaccine. 2006 Feb 27;24(9):1238-41
references.pmid: 16213632
references.citation: Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):16-9
references.pmid: 1729684
references.citation: Vaccine. 2007 Dec 12;25(51):8518-28
references.pmid: 17996988
references.citation: Curr Gene Ther. 2004 Dec;4(4):457-67
references.pmid: 15578994
references.citation: Trends Microbiol. 2009 Apr;17(4):146-50
references.pmid: 19307122
references.citation: Vaccine. 2008 Jan 10;26(2):153-7
references.pmid: 18069096
references.citation: J Virol. 2002 Dec;76(24):13097-100
references.pmid: 12438639
references.citation: Vaccine. 2004 Sep 9;22(27-28):3722-6
references.pmid: 15315852
references.citation: FEBS Lett. 2002 Jun 5;520(1-3):40-6
references.pmid: 12044867
references.citation: Vaccine. 2009 Feb 25;27(9):1354-64
references.pmid: 19150474
references.citation: Virus Res. 1999 Nov;64(2):107-23
references.pmid: 10518708
references.citation: Nucleic Acids Res. 1997 Mar 15;25(6):1194-202
references.pmid: 9092629
references.citation: Nucleic Acids Res. 1986 Jul 11;14(13):5125-43
references.pmid: 3526280
references.citation: Methods Mol Med. 2006;127:83-9
references.pmid: 16988448
references.citation: J Virol. 1998 Jan;72(1):73-83
references.pmid: 9420202
references.citation: Vaccine. 2003 May 16;21(17-18):2178-89
references.pmid: 12706709
references.citation: Nucleic Acids Res. 1990 Feb 25;18(4):937-47
references.pmid: 1690394
references.citation: Nature. 1983 Oct 13-19;305(5935):600-5
references.pmid: 6194440
references.citation: Infect Immun. 2002 Jul;70(7):3539-45
references.pmid: 12065493
references.citation: Nat Med. 2005 May;11(5):522-30
references.pmid: 15852016
references.citation: J Virol. 1998 Jun;72(6):4925-30
references.pmid: 9573260
references.citation: Gene Ther. 2003 Aug;10(15):1268-73
references.pmid: 12858192
references.citation: J Virol. 2003 Jan;77(2):1653-7
references.pmid: 12502885
references.citation: Infect Immun. 1999 Sep;67(9):4780-6
references.pmid: 10456931
references.citation: J Gen Virol. 2000 Mar;81(Pt 3):749-58
references.pmid: 10675413
references.citation: Curr Opin Mol Ther. 2007 Oct;9(5):498-504
references.pmid: 17932814
references.citation: Adv Virus Res. 2003;61:395-418
references.pmid: 14714438
references.citation: Vaccine. 2004 Dec 16;23(5):629-38
references.pmid: 15542183
references.citation: Drugs R D. 2008;9(3):137-45
references.pmid: 18457466
references.citation: J Infect Dis. 2007 Dec 15;196(12):1732-40
references.pmid: 18190252
references.citation: Emerg Infect Dis. 2006 Jun;12(6):887-93
references.pmid: 16707042